Latest news with #FutureHealthIndex2025
Time of India
2 days ago
- Health
- Time of India
Building Trust in Healthcare AI: India's Path from Potential to Practice
New Delhi: As India's healthcare sector grapples with rising patient volumes, workforce shortages and systemic capacity constraints, Artificial Intelligence (AI) is increasingly emerging as a practical and powerful tool to bridge critical gaps. Recent discussions among healthcare leaders and policymakers have spotlighted how AI is no longer just a futuristic concept but a present-day ally for clinicians navigating complex healthcare realities. The recently unveiled Future Health Index (FHI) 2025 India report was marked by an engaging discussion with some of India's leading healthcare experts and advocates. The event underscored how India is now poised to transition from viewing AI as a tool of potential to embracing it as a practical solution in real world healthcare settings. With a special address by H.E. Ms. Marisa Gerards, Ambassador of the Kingdom of the Netherlands to India, Nepal, and Bhutan, the event featured a thought-provoking panel discussion with leading healthcare experts including Mr. Neeraj Jain, Director - Growth Operations, Asia, Middle East and Europe (AMEE), PATH; Dr. Ratna Devi, Board Member at IAPO and CEO of DakshamA Health and Mr. Bharath Sesha, Managing Director, Philips Indian Subcontinent. The session was moderated by Ms. Prathiba Raju, Senior Assistant Editor at ETHealthWorld, The Economic Times Group. According to the India-specific findings in the FHI report, 76% of healthcare professionals believe AI will help improve patient outcomes, while over 80% feel AI can save lives by enabling timely care. These figures point to a growing confidence among India's clinical community in the technology's ability to enhance not replace human decision-making. 'India stands at a pivotal moment in its healthcare transformation,' said Bharath Sesha, Managing Director, Philips Indian Subcontinent. 'There is growing confidence in AI, not just as a tool for efficiency, but as a catalyst for improved outcomes, broader access, and more empowered healthcare professionals. The Future Health Index 2025 findings reaffirm what we've long believed: when applied with purpose, technology can bridge the gap between capability and capacity. Trust in both the technology and the intent behind it is essential to scaling AI in a meaningful way. Cross-sector collaboration is equally critical. By bringing together clinicians, technologists, policymakers, and patients, we can co-create solutions that are clinically relevant, ethically sound, and scalable across India's diverse healthcare ecosystem.' Global best practices suggest that collaboration is key. The development and deployment of AI in healthcare must involve a broad set of stakeholders. This inclusive approach is especially vital in countries like India, where the scale and diversity of the health system present both opportunities and risks. ' Healthcare innovation must be people-centric and globally responsible,' said H.E. Ms. Marisa Gerards, Ambassador of the Kingdom of the Netherlands to India, Nepal and Bhutan. 'During the launch of the 10th edition of Future Health Index 2025 report commissioned by Philips, we had a meaningful discussion with the Indian stakeholders thinking not just about what technology can do, but how it can be applied ethically, equitably, and effectively.' The findings from the report also reveal a broadening acceptance of AI in everyday practice. 72 per cent of professionals say it supports accurate, real-time clinical decision-making, while 75 per cent believe it is particularly valuable for training junior staff and expanding access in underserved areas. 'AI is no longer a choice it's the only viable path to delivering care at scale for a nation of 1.5 billion people,' noted Mr. Neeraj Jain, Director - Growth Operations, Asia, Middle East and Europe (AMEE), PATH. 'But for it to work, our entire ecosystem must be prepared to adopt it responsibly. That means accelerating adoption while ensuring AI tools are developed in close consultation with clinicians, so they are fit for purpose and trusted at the point of care.' While trust in AI is growing, it remains conditional. 67 per cent of healthcare professionals voiced concern over data bias, highlighting the risk of inequities if AI systems are not trained on representative datasets. Questions around legal liability (44%) and defined guardrails for clinical use (45%) also persist. ' Building trust in AI is critical,' said Dr. Ratna Devi, Board Member at IAPO and CEO of DakshamA Health. 'People need clarity on how these tools work and assurance that they are safe and reliable. The doctor–patient ratio in India is unlikely to change dramatically, so AI must be seen as a tool to augment, not replace doctors. It can enhance care delivery, improve efficiency, and help drive change, but it must always complement the human touch.' The FHI 2025 findings also highlight the importance of sustained investment in education and digital capacity-building. Empowering healthcare workers to understand and trust AI, will be essential to mainstream adoption and to ensuring long-term success. As AI moves further into the clinical mainstream, India finds itself at a pivotal moment. With rising readiness among professionals, deepening digital infrastructure, and increasing cross-sectoral momentum - the time to build trust and act is now. Download the full FHI 2025 India Report here Disclaimer - The above content is non-editorial, and ET Healthworld hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
Yahoo
18-06-2025
- Health
- Yahoo
Philips launches new point-of-care ultrasound system
Philips has launched a new point-of-care (POC) ultrasound system designed to broaden the accessibility of ultrasound for diagnostic and therapeutic interventions. The Flash 5100 POC system is applicable for use cases in anaesthesia, critical care, emergency medicine, and musculoskeletal imaging. The system is built on Philips' existing cardiology and general imaging ultrasound technology. Philips describes the system as utilising an 'encounter-based' workflow, allowing clinicians to perform and document exams in real time. According to the company, this makes the new system best placed for use in high-pressure environments such as the emergency room (ER) and trauma units. Following Philips' recent Future Health Index 2025 report, which revealed that 33% of patients surveyed have experienced worsening health due to delays in seeing a doctor, with one in four patients ending up in hospital due to long wait times, the company noted that POC ultrasound is becoming increasingly vital. Jeff Cohen, global business leader of ultrasound at Philips, said the new system represents a 'major leap forward' in Philips' commitment to the POC ultrasound segment, with the system joining Philips' portfolio. This includes its app-based Lumify ultrasound system, which received 510(k) clearance from the US Food and Drug Administration (FDA) in 2015. 'Designed for speed, mobility, and precision, the Flash 5100 empowers clinicians to make confident, real-time decisions in the most urgent settings – at the bedside, in the ICU, the emergency department, or the OR [operating room],' Cohen said. The Flash 5100 is also designed to support Philips' tele-ultrasound solution, Collaboration Live, in which clinicians can connect with remote colleagues in real-time to share images and guidance. 'In today's overburdened clinical landscape, that kind of remote collaboration isn't just helpful – it's essential,' Cohen added. According to Ashley Clarke, senior healthcare analyst at GlobalData, POC ultrasound devices in the US currently have an annual growth rate of around 3.75%. Representing one of the highest uptake rates of ultrasound among healthcare systems and clinics in the US, Clarke said that the figure is primarily driven by the fact that POC ultrasound systems cost between $5,000 and $20,000 on average, whereas traditional ultrasound systems may cost anywhere from $50,000 to $200,000. A market model by GlobalData forecasts that the handheld ultrasound market, of which POC ultrasound systems are a part, will reach a valuation of around $43.3bn by 2034, up from $29.2bn in 2024. "Philips launches new point-of-care ultrasound system" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
15-05-2025
- Health
- Business Wire
Philips Future Health Index 2025 Report Highlights Significant Trust Gap in Healthcare AI Between Clinicians and Patients
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, 'Building trust in healthcare AI,' spotlighting the state of healthcare and uncovering a significant trust gap between healthcare professionals (HCPs) and patients around the role of AI in healthcare. This 10 th edition report, commissioned by Philips, reveals a healthcare system under mounting strain and signals that AI can help. However, gaps in trust in AI threaten to stall progress. With feelings of stress, frustration and burnout, the report finds that almost one quarter of HCPs say they wouldn't pursue a career in healthcare if they could go back in time. Patients are also feeling the strain, with the longest wait times to see a specialist averaging almost two months, which can lead to increased anxiety and potentially poorer outcomes. While a majority of HCPs (63%) are optimistic that AI could improve patient outcomes, less than half of patients surveyed are optimistic that AI can improve healthcare. The gap widens even further among patients aged 45 or over, with just 33% being positive about AI's role in improving healthcare. This year's Future Health Index also illustrates HCPs' growing recognition of the transformative potential of AI in enhancing their work and the care they provide to patients. Nearly two-thirds (62%) value AI's ability to enhance the patient experience through shorter procedure times and reduced wait times for patients. Moreover, 85% state that AI can reduce their administrative burden, and 74% see AI improving patient access through increased capacity and throughput as well as increased face-to-face time with patients, reinforcing the crucial role AI can play in speeding healthcare delivery. 'AI is reshaping healthcare – but its future depends on trust, transparency and collaboration with clinicians and patients,' said Jeff DiLullo, Chief Region Leader, Philips North America. 'Together, we can unlock AI's potential to reduce provider burnout and elevate patient care.' About the Future Health Index 2025 The Future Health Index is commissioned by Philips and is the largest global survey of its kind, analyzing the priorities and perspectives of more than 1,900 healthcare professionals and more than 16,000 patients across 16 countries. In its 10th edition, the Future Health Index 2025 investigates how innovative technologies, particularly AI, can empower healthcare professionals to deliver better care for more people. For more information, or to download the full FHI 2025 U.S. report, visit About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at
